Stay updated on RTA 408 Capsules in Friedreich's Ataxia Clinical Trial
Sign up to get notified when there's something new on the RTA 408 Capsules in Friedreich's Ataxia Clinical Trial page.

Latest updates to the RTA 408 Capsules in Friedreich's Ataxia Clinical Trial page
- Check3 days agoChange DetectedThe study record page now shows a 403 Forbidden error, blocking access to the trial details and related links. The previous content and documents listed on the page are no longer accessible.SummaryDifference22%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page now includes a new 150 mg dosing arm for Part 2, long-extension/open-label options, IPD sharing documents, and new locations; several Part 1 dose cohorts and placebo arms were removed, reflecting a revised trial structure.SummaryDifference5%

- Check24 days agoChange DetectedFooter revision indicator has been updated from v3.6.5 to v3.6.6, reflecting a software update to the site.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a minor update to the page. No changes to the study details or other visible content are indicated.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a minor update to the study details page. This suggests a small metadata or formatting adjustment rather than substantive changes to the study content.SummaryDifference0.0%

- Check81 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3. This indicates a minor update to the page’s revision history for the study record.SummaryDifference0.0%

Stay in the know with updates to RTA 408 Capsules in Friedreich's Ataxia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RTA 408 Capsules in Friedreich's Ataxia Clinical Trial page.